Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Meng

Showing results (351-360 of 358) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 358 results.
Emerging Microbes & Infections|January 20, 2022
B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responsesKe Lin, Yawen Zhou, Jingwen Ai, et al.
Clinical and Translational Medicine|May 13, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancerChen Liang, Mu Ye, Lei Yu, et al.
Science Immunology|March 24, 2023
DNA repair mechanisms that promote insertion-deletion events during immunoglobulin gene diversificationQian Hao, Chuanzong Zhan, Chaoyang Lian, et al.
Nature Cell Biology|January 23, 2024
C-to-G editing generates double-strand breaks causing deletion, transversion and translocationMin Emma Huang, Yining Qin, Yafang Shang, et al.
Cell|April 25, 2023
Mesoscale DNA feature in antibody-coding sequence facilitates somatic hypermutationYanyan Wang, Senxin Zhang, Xinrui Yang, et al.
Journal of Translational Medicine|October 1, 2024
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumorsDao-Han Zhang, Chen Liang, Shu-Yang Hu, et al.
EMBO Molecular Medicine|October 21, 2021
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibodyTingting Li, Hongmin Cai, Yapei Zhao, et al.
Nature Communications|January 20, 2024
Macro CD5L<sup>+</sup> deteriorates CD8<sup>+</sup>T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinomaJia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, et al.
Pageof 36

Showing results (351-360 of 358) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 358 results.
Emerging Microbes & Infections|January 20, 2022
B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responsesKe Lin, Yawen Zhou, Jingwen Ai, et al.
Clinical and Translational Medicine|May 13, 2025
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancerChen Liang, Mu Ye, Lei Yu, et al.
Science Immunology|March 24, 2023
DNA repair mechanisms that promote insertion-deletion events during immunoglobulin gene diversificationQian Hao, Chuanzong Zhan, Chaoyang Lian, et al.
Nature Cell Biology|January 23, 2024
C-to-G editing generates double-strand breaks causing deletion, transversion and translocationMin Emma Huang, Yining Qin, Yafang Shang, et al.
Cell|April 25, 2023
Mesoscale DNA feature in antibody-coding sequence facilitates somatic hypermutationYanyan Wang, Senxin Zhang, Xinrui Yang, et al.
Journal of Translational Medicine|October 1, 2024
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumorsDao-Han Zhang, Chen Liang, Shu-Yang Hu, et al.
EMBO Molecular Medicine|October 21, 2021
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibodyTingting Li, Hongmin Cai, Yapei Zhao, et al.
Nature Communications|January 20, 2024
Macro CD5L<sup>+</sup> deteriorates CD8<sup>+</sup>T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinomaJia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, et al.
Pageof 36